Literature DB >> 1285135

Serotype specificity of vaccine-induced immunity to pertussis.

N W Preston1, E J Carter.   

Abstract

Two large epidemics of pertussis occurred in Britain during 1977-79 and 1981-83, following a decline in vaccine uptake in the mid-1970s. Serotype 1,3 predominated during both epidemics but serotypes 1,2 and 1,2,3 constituted 32% (243 of 769) of the isolates from unvaccinated children compared with only 10% (9 of 86) of the isolates from vaccinated children (p < 0.005). Whole-cell vaccines, although effective against infection with all serotypes, have a higher efficacy against serotypes 1,2 and 1,2,3 than against serotype 1,3. These data suggest that not only should acellular vaccines contain agglutinogens specific for each serotype but trials should demonstrate efficacy against all three serotypes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1285135

Source DB:  PubMed          Journal:  Commun Dis Rep CDR Rev        ISSN: 1350-9349


  8 in total

1.  Use of monoclonal antibodies to serotype Bordetella pertussis isolates: comparison of results obtained by indirect whole-cell enzyme-linked immunosorbent assay and bacterial microagglutination methods.

Authors:  Raymond S W Tsang; Michelle L Sill; Abdolreza Advani; Dorothy Xing; Penny Newland; Hans Hallander
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

2.  Analysis of Bordetella pertussis populations in European countries with different vaccination policies.

Authors:  S C M van Amersfoorth; L M Schouls; H G J van der Heide; A Advani; H O Hallander; K Bondeson; C H W von König; M Riffelmann; C Vahrenholz; N Guiso; V Caro; E Njamkepo; Q He; J Mertsola; F R Mooi
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

3.  Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type.

Authors:  David J Litt; Shona E Neal; Norman K Fry
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

4.  Molecular epidemiology of Bordetella pertussis and analysis of vaccine antigen genes from clinical isolates from Shenzhen, China.

Authors:  Shuang Wu; Qinghua Hu; Chao Yang; Haijian Zhou; Hongyu Chen; Yanwei Zhang; Min Jiang; Yuxiang He; Xiaolu Shi
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-08-18       Impact factor: 3.944

5.  Application of pulsed field gel electrophoresis to the 1993 epidemic of whooping cough in the UK.

Authors:  S N Syedabubakar; R C Matthews; N W Preston; D Owen; V Hillier
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

6.  Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease.

Authors:  Frances Alexander; Mary Matheson; Norman K Fry; Briony Labram; Andrew R Gorringe
Journal:  Clin Vaccine Immunol       Date:  2012-09-05

7.  Impact of age and vaccination history on long-term serological responses after symptomatic B. pertussis infection, a high dimensional data analysis.

Authors:  Inonge van Twillert; Axel A Bonačić Marinović; Betsy Kuipers; Jacqueline A M van Gaans-van den Brink; Elisabeth A M Sanders; Cécile A C M van Els
Journal:  Sci Rep       Date:  2017-01-16       Impact factor: 4.379

8.  Bordetella pertussis isolates in Finland: serotype and fimbrial expression.

Authors:  Eriikka Heikkinen; Dorothy K Xing; Rose-Marie Olander; Jukka Hytönen; Matti K Viljanen; Jussi Mertsola; Qiushui He
Journal:  BMC Microbiol       Date:  2008-09-25       Impact factor: 3.605

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.